Abstract
Introduction Vaccines are essential to prevent infection and reduce morbidity of infectious diseases. Previous evidence has shown that migrants and refugees are particularly vulnerable to exclusion and discrimination, and low COVID-19 vaccine intention and uptake were observed among refugees globally. This study aimed to develop and internally validate prediction models of COVID-19 vaccine uptake by nationality.
Methods This is a nested prognostic population-based cross-sectional analysis. Data was collected between June and October 2022 in Sin-El-Fil, a district of Beirut, Lebanon. All Syrian adults and a random sample of adults from low-socioeconomic status neighborhoods were invited to participate in a telephone survey. The main outcome was uptake of COVID-19 vaccine. Predictors of COVID-19 vaccine uptake were assessed using LASSO regression for Lebanese and Syrian nationalities, respectively.
Results Of 2,045 participants, 79% were Lebanese, 18% Syrians and 3% of other nationalities. COVID-19 vaccination uptake was higher among Lebanese (85% (95%CI:82-86) compared to Syrians (47% (95% CI:43-51)) (P<0.001); adjusted odds ratio (aOR) 6.8 (95%CI:5.5-8.4). Predictors of uptake of one or more vaccine dose for Lebanese were older age, presence of an older adult in the household, higher education, greater asset-based wealth index, private healthcare coverage, feeling susceptible to COVID-19, belief in the safety and efficacy of vaccines and previous receipt of flu vaccine. For Syrians they were older age, male, completing school or higher education, receipt of cash assistance, presence of comorbidities, belief in the safety and efficacy of vaccines, previous receipt of flu vaccine, and legal residency status in Lebanon.
Conclusions These findings indicate barriers for vaccine uptake in Syrian migrants and refugees, including legal residency status. They call for urgent action to enable equitable access to vaccines by raising awareness about the importance of vaccination and the targeting of migrant and refugee populations through vaccination campaigns.
What is already known on this topic Vaccines are essential to prevent infection and reduce morbidity of infectious diseases, and vulnerable populations may lack access to vaccination campaigns.
What this study adds To the best of our knowledge, no studies have examined compared predictors of COVID-19 vaccine uptake and measured the rate of vaccination among between Syrian migrants and refugees and their Lebanese host communities. This study illustrates a clear difference in vaccine uptake between nationalities and developed prediction models among the Syrian and Lebanese that identified differential predictors of COVID-19 vaccine uptake for each population.
How this study might affect research, practice or policy These findings indicate barriers for vaccine uptake in Syrian migrants and refugees, including legal status, and calls for urgent action to enable access to vaccines by raising awareness about the importance of vaccination against COVID-19 in vulnerable groups and targeting migrant and refugee populations through vaccination campaigns.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the International Development Research Centre (IDRC), Canada
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was reviewed and approved by the American University of Beirut Social and Behavioral Sciences Institutional Review Board (reference: SBS-2021-0268).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵¶ Membership of the CAEP Study Group is listed in the Acknowledgments.
The abstract was revised and edited.
Data sharing
The anonymized data can be obtained upon reasonable request from the Center for Research on Population and Health at the American University of Beirut (crph{at}aub.edu.lb).
